Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| United States Department of Veterans Affairs | 5 | 2026 | 727 | 1.050 |
Why?
|
| Community Mental Health Services | 1 | 2026 | 43 | 0.930 |
Why?
|
| Mental Health Services | 2 | 2024 | 282 | 0.850 |
Why?
|
| Professional Role | 1 | 2024 | 76 | 0.820 |
Why?
|
| Rural Population | 1 | 2026 | 271 | 0.790 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2024 | 140 | 0.760 |
Why?
|
| Attitude of Health Personnel | 2 | 2024 | 702 | 0.720 |
Why?
|
| Veterans | 4 | 2026 | 1805 | 0.680 |
Why?
|
| Anxiety Disorders | 2 | 2024 | 731 | 0.680 |
Why?
|
| Telemedicine | 2 | 2024 | 515 | 0.610 |
Why?
|
| Health Personnel | 1 | 2024 | 550 | 0.600 |
Why?
|
| Qualitative Research | 5 | 2026 | 699 | 0.580 |
Why?
|
| Registries | 1 | 2024 | 1617 | 0.520 |
Why?
|
| Mental Disorders | 1 | 2022 | 896 | 0.430 |
Why?
|
| Interviews as Topic | 2 | 2026 | 444 | 0.400 |
Why?
|
| United States | 6 | 2026 | 11865 | 0.270 |
Why?
|
| Burns | 1 | 2024 | 91 | 0.200 |
Why?
|
| Quantum Dots | 1 | 2022 | 16 | 0.190 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2022 | 32 | 0.190 |
Why?
|
| Videoconferencing | 1 | 2022 | 21 | 0.190 |
Why?
|
| Health Services Accessibility | 2 | 2026 | 694 | 0.180 |
Why?
|
| Mental Health | 2 | 2023 | 370 | 0.180 |
Why?
|
| Microscopy, Electron | 1 | 2022 | 310 | 0.180 |
Why?
|
| Implosive Therapy | 1 | 2024 | 100 | 0.180 |
Why?
|
| Mentoring | 1 | 2023 | 83 | 0.180 |
Why?
|
| Feasibility Studies | 1 | 2024 | 813 | 0.170 |
Why?
|
| Firearms | 1 | 2021 | 58 | 0.160 |
Why?
|
| Cell Membrane | 1 | 2022 | 450 | 0.160 |
Why?
|
| Wounds, Gunshot | 1 | 2021 | 146 | 0.160 |
Why?
|
| Cancer Survivors | 1 | 2023 | 272 | 0.150 |
Why?
|
| Psychotherapy | 1 | 2022 | 248 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2022 | 499 | 0.150 |
Why?
|
| HIV-1 | 1 | 2022 | 484 | 0.140 |
Why?
|
| Exercise | 1 | 2024 | 863 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 912 | 0.140 |
Why?
|
| Middle Aged | 4 | 2026 | 28511 | 0.140 |
Why?
|
| Humans | 12 | 2026 | 130854 | 0.140 |
Why?
|
| Clinical Competence | 1 | 2024 | 1055 | 0.130 |
Why?
|
| Adult | 4 | 2026 | 31238 | 0.130 |
Why?
|
| Trichechus manatus | 1 | 2017 | 1 | 0.130 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2017 | 49 | 0.130 |
Why?
|
| Complementarity Determining Regions | 1 | 2017 | 26 | 0.130 |
Why?
|
| Depression | 1 | 2024 | 1321 | 0.120 |
Why?
|
| Penaeidae | 1 | 2014 | 3 | 0.110 |
Why?
|
| Aquaculture | 1 | 2014 | 7 | 0.110 |
Why?
|
| Seafood | 1 | 2014 | 9 | 0.110 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2024 | 875 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 4017 | 0.100 |
Why?
|
| Male | 4 | 2026 | 64763 | 0.090 |
Why?
|
| Female | 4 | 2026 | 70550 | 0.090 |
Why?
|
| Neoplasms | 1 | 2023 | 2955 | 0.070 |
Why?
|
| Transcriptome | 1 | 2014 | 1129 | 0.070 |
Why?
|
| Aged | 1 | 2026 | 20970 | 0.070 |
Why?
|
| Pandemics | 2 | 2023 | 1158 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2024 | 220 | 0.050 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2022 | 2 | 0.050 |
Why?
|
| Patients | 1 | 2023 | 122 | 0.050 |
Why?
|
| Behavior Therapy | 1 | 2024 | 271 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2023 | 240 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 104 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2023 | 222 | 0.040 |
Why?
|
| Safety | 1 | 2021 | 215 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2023 | 407 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1457 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2022 | 376 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2022 | 297 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2022 | 400 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1269 | 0.040 |
Why?
|
| Antibody Diversity | 1 | 2017 | 9 | 0.030 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2017 | 19 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 73 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2022 | 769 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2017 | 222 | 0.030 |
Why?
|
| Mammals | 1 | 2017 | 255 | 0.030 |
Why?
|
| Daphnia | 1 | 2014 | 3 | 0.030 |
Why?
|
| Crustacea | 1 | 2014 | 6 | 0.030 |
Why?
|
| Immune System | 1 | 2014 | 99 | 0.030 |
Why?
|
| Parents | 1 | 2021 | 1105 | 0.030 |
Why?
|
| Quality of Life | 1 | 2024 | 2082 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2014 | 162 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 653 | 0.020 |
Why?
|
| DNA Replication | 1 | 2014 | 362 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2014 | 507 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 418 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 12913 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1682 | 0.020 |
Why?
|
| Genomics | 1 | 2014 | 1623 | 0.020 |
Why?
|
| Animals | 2 | 2017 | 33981 | 0.010 |
Why?
|
| Child | 1 | 2021 | 26215 | 0.010 |
Why?
|